Literature DB >> 21477985

Influence of syllable train length and performance end effects on estimation of phonation threshold pressure.

Katherine Y Faver1, Laura W Plexico, Mary J Sandage.   

Abstract

OBJECTIVES: The purpose of this study was to determine whether the number of syllables collected and performance end effects had a significant effect on phonation threshold pressure (PTP) estimates.
METHODS: Ten adult females with normal voices produced five- and seven-syllable trains of /pi/ at low, modal, and high pitches. The results were analyzed using repeated-measures analysis of variance to determine whether a difference existed in PTP when a five-syllable train was collected versus when a seven-syllable train was collected and whether the typically discarded first and last syllables within a train differed from the middle syllables.
RESULTS: The results indicated that there was no significant difference in estimated PTP values when calculated from a five-syllable versus a seven-syllable train or between the first, middle, and last syllables within a train.
CONCLUSIONS: Based on these findings, it appears that a five-syllable train provides adequate information from which to estimate PTP values. Furthermore, these findings also suggest that within the five-syllable train, any three adjacent syllables could be used to estimate PTP. These findings are significant in developing a clinically standardized, effective, and efficient method for collecting PTP.
Copyright © 2012 The Voice Foundation. Published by Mosby, Inc. All rights reserved.

Mesh:

Year:  2011        PMID: 21477985     DOI: 10.1016/j.jvoice.2010.10.021

Source DB:  PubMed          Journal:  J Voice        ISSN: 0892-1997            Impact factor:   2.009


  1 in total

1.  Individual Monitoring of Vocal Effort With Relative Fundamental Frequency: Relationships With Aerodynamics and Listener Perception.

Authors:  Yu-An S Lien; Carolyn M Michener; Tanya L Eadie; Cara E Stepp
Journal:  J Speech Lang Hear Res       Date:  2015-06       Impact factor: 2.297

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.